Literature DB >> 2558335

Renin-promoter SV40 large T-antigen transgenes induce tumors irrespective of normal cellular expression of renin genes.

C Sola1, D Tronik, M Dreyfus, C Babinet, F Rougeon.   

Abstract

Chimeric genes containing the 5'-flanking regions of the mouse renin genes, Ren1 and Ren2, associated with the early region of the simian virus 40 (SV40) were constructed. The two recombinant genes which contain, respectively, 0.45- and 2.5-kb the Ren1 and Ren2 5'-flanking sequences, named Ren1Tag and Ren2Tag, were microinjected into fertilized eggs. Tumors arose after a latency of 5-9 months in mouse lines harboring these hybrid genes except for one, in which a different and earlier pathology was observed (peripheral neuropathies). Most of the pathologies developed by these transgenic mice reflect the tumorigenic spectrum of the SV40 early region gene (choroid plexus, kidney, intestinal tumors, and peripheral neuropathies). None of these tumors arose from renin-producing cells nor produced renin. As suggested by the tumor pathology, the expression of the SV40 large T-antigen did not follow the normal expression of the Ren1 and the Ren2 genes since SV40 large T-antigen mRNA was found in tissues which normally do not express renin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558335

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  3 in total

1.  Telomerase immortalization of principal cells from mouse collecting duct.

Authors:  Stacy L Steele; Yongren Wu; Robert J Kolb; Monika Gooz; Courtney J Haycraft; Kent T Keyser; Lisa Guay-Woodford; Hai Yao; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-06

2.  Inappropriate splicing of a chimeric gene containing a large internal exon results in exon skipping in transgenic mice.

Authors:  R L Davisson; N Nuutinen; S T Coleman; C D Sigmund
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

3.  In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer.

Authors:  T Yamada; M Horiuchi; R Morishita; L Zhang; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.